| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
An early ENAC inhibitor that reduces sodium reabsorption in the kidneys, promoting diuresis and decreasing fluid retention. | ||||||
Triamterene | 396-01-0 | sc-213103A sc-213103 | 1 g 5 g | $22.00 $54.00 | ||
Blocks sodium reabsorption in the renal tubules, leading to increased urine output and reduced blood pressure. | ||||||
Eplerenone | 107724-20-9 | sc-203943 sc-203943A | 10 mg 50 mg | $110.00 $624.00 | 4 | |
An aldosterone receptor antagonist that indirectly inhibits ENAC by countering the effects of aldosterone, a hormone that promotes sodium and water retention. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Also an aldosterone receptor antagonist that affects sodium balance and indirectly impacts ENAC activity. | ||||||
Aclidinium Bromide | 320345-99-1 | sc-480200 | 100 mg | $388.00 | ||
Used as a bronchodilator for COPD, aclidinium has ENAC-inhibiting properties. | ||||||
Tolvaptan | 150683-30-0 | sc-364638 sc-364638A | 10 mg 50 mg | $125.00 $624.00 | ||
A vasopressin V2 receptor antagonist that influences water reabsorption in the renal tubules, increasing urine output and sodium excretion. | ||||||
Benazepril Free base | 86541-75-5 | sc-337551 | 1 g | $1040.00 | ||
An ACE inhibitor that indirectly affects ENAC by reducing angiotensin II levels, a hormone that promotes sodium retention. | ||||||
Lixivaptan | 168079-32-1 | sc-489378 | 5 mg | $84.00 | ||
Another vasopressin V2 receptor antagonist that influences water reabsorption in the kidneys, affecting sodium balance. | ||||||